Investor Alert

Market Pulse Archives

Feb. 6, 2018, 12:15 p.m. EST

Ziopharm stock rallies after company says nothing to see here, folks

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    ZIOPHARM Oncology Inc. (ZIOP)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Emma Court

Ziopharm Oncology Inc. /zigman2/quotes/200291745/composite ZIOP +1.23% shares rose 6.8% in Tuesday trade after the company said that rumors about plans for a stock offering were baseless and that the company has no plans to do so "at this time." Ziopharm said it "knows of no developments at the Company that would be the cause of the recent volatility and decline in the stock price." Company shares have dropped 21% over the last three months and 44.5% over the last 12 months. Ziopharm has, however, been working to find corporate and financial partners to move its business forward, interim Chief Operating Officer David Mauney said. As of the end of last year, the company had nearly $71 million of unrestricted cash and $34.6 million from pre-payment for programs at MD Anderson Cancer Center. Ziopharm shares have declined 6.2% to $3.70 over the last month, compared with a 6.3% decline in the S&P 500 /zigman2/quotes/210599714/realtime SPX -1.05% .

US : U.S.: Nasdaq
$ 3.30
+0.04 +1.23%
Volume: 1.50M
Feb. 21, 2020 4:00p
P/E Ratio
Dividend Yield
Market Cap
$590.16 million
Rev. per Employee
-35.48 -1.05%
Volume: 2.12B
Feb. 21, 2020 5:16p

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.